Alcon Launches Systane iLux2 MGD Thermal Pulsation System
Tuesday, November 15 2022 | 14 h 22 min | New Products, News, OptikTech, Press Release
Alcon today announced the Canadian launch of its latest innovation to treat patients with dry eye: the Systane® iLux2® Meibomian Gland Dysfunction (MGD) Thermal Pulsation System.
The Systane iLux2 treatment system is the only all-in-one, portable MGD device that can help Eye Care Professionals (ECPs) both evaluate their MGD patients and then effectively treat them through customizable control of heat and expression of their meibomian glands. To help educate patients on the benefits of this treatment, the Systane iLux2 now has advanced imaging capabilities used for meibography, enabling ECPs to capture white light and infrared photos of the meibomian glands, as well as high-definition (HD) video and images of the treatment process.
“Around 56% of patients see four or more eye care providers in search of proper diagnosis and relief,” said Dr. Walter Whitley, Optometrist at Virginia Eye Consultants. “With the new Systane iLux2 MGD Thermal Pulsation System, I can efficiently evaluate my MGD patients and educate them on their need for Systane iLux2.”
The new imagining capabilities’ of Systane iLux2 MGD Thermal Pulsation System helps the device expand on its already efficacious treatment capabilities, giving patients 12 months efficacy with a single 8-to-12-minute treatment. In a post-hoc review of a recent study on 236 patients, 87% of patients with severe baseline MGD symptoms reported having only mild-to-moderate symptoms at 12 months post-treatment. Moreover, 78% of patients with moderate baseline symptoms had no-to-mild symptoms at 12 months post-treatment.
“Alcon is committed to continually innovating our dry eye portfolio with industry-leading product offerings, so that ECPs are able to respond to their patient’s needs,” said Chris Gruhn, General Manager of Alcon Canada. “By allowing patients to visualize the disease, and track their results over time, the all-in-one updated SystaneiLux2 MGD Thermal Pulsation System will assist eye care professionals in further building trust with their patients.”
Click HERE for the full press release.
